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 35 
Background: The mechanisms whereby neuroinflammation negatively affects neuronal 36 
function in the hypothalamus are not clear. Our previous study determined that obesity-37 
mediated chronic inflammation elicits sex-specific impairment in reproductive function 38 
via reduction in spine density in GnRH neurons. Neuroinflammation and subsequent 39 
decrease in GnRH neuron spine density was specific for male mice, while protection in 40 
females was independent of ovarian estrogens.  41 
Methods: To examine if neuroinflammation-induced cytokines can directly regulate 42 
GnRH gene expression, herein we examined signaling pathways and mechanisms in 43 
males in vivo and in GnRH-expressing cell line, GT1-7.  44 
Results: GnRH neurons express cytokine receptors, and chronic or acute 45 
neuroinflammation represses GnRH gene expression in vivo. Leukemia inhibitory factor 46 
(LIF) in particular represses GnRH expression in GT1-7 cells, while other cytokines do 47 
not. STAT3 and MAPK pathways are activated following LIF treatment, but only MAPK 48 
pathway, specifically p38α, is sufficient to repress GnRH gene. LIF induces cFOS that 49 
represses GnRH gene via the -1793 site in the enhancer region. In vivo, following high 50 
fat diet, cFOS is induced in GnRH neurons and neurons juxtaposed to the leaky blood 51 
brain barrier of the organum vasculosum of the lamina terminalis, but not in the neurons 52 
further away.  53 
Conclusion: Our results indicate that the increase in LIF due to neuroinflammation 54 
induces cFOS and represses GnRH gene. Therefore, in addition to synaptic changes in 55 
GnRH neurons, neuroinflammatory cytokines directly regulate gene expression and 56 
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reproductive function, and the specificity for neuronal targets may stem from the 57 
proximity to the fenestrated capillaries.  58 
 59 
Introduction 60 
Gonadotropin releasing-hormone (GnRH) is the final brain output for the 61 
regulation of reproduction. GnRH neurons, which are scattered in the hypothalamus, 62 
synthesize and secrete GnRH that acts on the anterior pituitary to stimulate the 63 
synthesis and secretion of luteinizing hormone (LH) and follicle stimulating hormone 64 
(FSH) from gonadotrope cells [1, 2]. LH and FSH act on the gonads to promote 65 
steroidogenesis and gametogenesis. GnRH neuronal processes, named “dendrons”, by 66 
Herbison group [3], form an interwoven network that receives direct synaptic and 67 
neuropeptide input from upstream regulatory neurons, most notably kisspeptin [4, 5]. 68 
This GnRH network integrates other signals that impinge on reproduction, such as 69 
stress [6, 7], endocrine disruptors [8], circadian rhythms [9, 10], metabolism [11, 12], 70 
and acute inflammation during infection [13-15].  71 
Previous studies have implicated acute inflammation, elicited with an injection of 72 
lipopolysaccharide (LPS), in the impairment of reproductive function [14, 16, 17]. LPS 73 
challenged rodents exhibited reduced levels of LH and GnRH mRNA, diminished 74 
release of LH and GnRH, and increased levels of pro-inflammatory cytokines, such as 75 
tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 in the circulation [14, 18-20]. 76 
Centrally administered cytokines also provoked reduced LH and GnRH levels, but the 77 
mechanism whereby these cytokines mediate their effects is unknown [16, 17, 21-23]. 78 
More recently, our group determined that low-grade, chronic inflammation caused by 79 
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high fat diet (HFD)-induced obesity may also directly affect GnRH neurons, resulting in 80 
reduced levels of LH in circulation and diminished GnRH mRNA levels in the 81 
hypothalamus, specifically in male mice [24]. We, and others, have reported that diet-82 
induced obese mice and people exhibited increased levels of pro-inflammatory 83 
cytokines, TNF-α, IL-1β, and IL-6, in circulation [24, 25] and in the hypothalamus, at the 84 
mRNA level and protein level [24, 26]. Additionally, we also identified that leukemia 85 
inhibitory factor (LIF), a member of the IL-6 family, is increased in the circulation and 86 
locally produced in male mice hypothalami in obesity [24]. Interestingly, LIF is increased 87 
in a sex-specific manner only in males that exhibit reduction in GnRH mRNA and 88 
gonadotropin hormones, but not in females that lack changes in GnRH or gonadotropin 89 
hormones. IL-6, a prototypical member of the family, on the other hand, is increased in 90 
both sexes. Our previous study postulated that impairment of GnRH neurons stems 91 
from reduction in spine density and consequently the connectivity of the GnRH network 92 
[24]. However, GnRH neurons express several cytokine receptors [27] and 93 
inflammation-induced cytokines may directly regulate intracellular signaling pathways in 94 
the GnRH neurons. 95 
Herein, we focus on delineating the mechanisms by which inflammatory 96 
cytokines influence GnRH gene expression to provide insight into the etiology of 97 
neuroinflammation-induced impairment of reproductive function. TNF-α, IL-1β, and IL-6 98 
are key players in the regulation of immune response and inflammatory processes 99 
during infection [28]. In the central nervous system, TNF-α and IL-1β regulate synaptic 100 
plasticity, neurodegeneration, learning and memory [29-32]. During infection, both of 101 
these cytokines mediate the physiological and behavioral responses in sickness such 102 
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as, inducing fever, inhibiting food intake, causing nausea and fatigue [33-35]. TNF-α 103 
and IL-1β mediate their effects through activation of downstream signaling molecules: 104 
nuclear factor-kappa B (NFκ-B), Janus kinase and signal transducers and activators of 105 
transcription pathway (JAK-STAT) and mitogen activated protein kinases (MAPK) [36-106 
38]. Similarly, IL-6 is produced in response to infection and stress, and in turn stimulates 107 
various cell populations, also through the JAK-STAT and MAPK pathways [39]. In the 108 
brain, IL-6 is involved in degenerative responses. [40, 41]. However, IL-6 is also 109 
induced following TNF-α or IL-1β treatment and is involved in the negative feedback 110 
that ultimately contributes to the dampening of the immune response and activating 111 
tissue repair [42].  112 
LIF is a member of IL-6 family that is induced during inflammatory response [43]. 113 
However, its functions are not limited to inflammation: LIF has been demonstrated to 114 
play a crucial, non-redundant role in embryo implantation in both mice and humans [44-115 
46]. LIF also maintains stem cells and regulates differentiation of germ cells [47, 48]. In 116 
the brain, LIF regulates neuronal function and neuronal response to injury [49-51]. With 117 
respect to GnRH neurons, LIF has been shown to regulate the migration of GN11 118 
immature GnRH neuron cell line and regulate the release of GnRH in GT1-7 cells [52-119 
54]. LIF binds its specific receptor, which, similarly to the other members of the IL-6 120 
family, recruits and signals through the GP130 signals transducer, activating JAK-STAT 121 
pathway [45].   122 
Signaling pathways involved in the regulation of GnRH gene transcription by any 123 
of these cytokines have not been elucidated. GnRH neurons in the rodent 124 
hypothalamus are located in the preoptic area surrounding organum vasculosum 125 
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laminae terminalis (OVLT) and send long processes to the median eminence (ME) 126 
where secretion occurs from the terminals. Both OVLT and ME are areas that contain 127 
fenestrated capillaries and a leaky blood-brain barrier [55]. A subpopulation of GnRH 128 
neurons extends their processes into the OVLT and across the blood-brain barrier, 129 
where they may be able to directly respond to circulating molecules, including cytokines 130 
[56]. OVLT and surrounding thermoregulatory neurons are involved in changes in body 131 
temperature and inducing fever in response to systemic inflammation. Pyrogenic, pro-132 
inflammatory cytokines, TNF-α, IL-1β and IL-6, produced locally in the hypothalamus, or 133 
from the circulation via fenestrated capillaries in the OVLT, stimulate thermoregulatory 134 
neurons to increase the body temperature [57-60]. We postulate that these cytokines 135 
directly regulate GnRH neurons in the proximity to OVLT. 136 
 About 800-1200 GnRH neurons are scattered throughout the forebrain of a 137 
mouse [61]. This poses a challenge for molecular studies of GnRH neurons in vivo.  138 
GT1-7 cells are the only model of mature, terminally differentiated, GnRH-producing 139 
neurons, and have been used to identify regulatory elements and transcription factors 140 
important for GnRH transcription [62, 63]. GT1-7 cells allow for the investigation of 141 
molecular mechanisms and direct effects on GnRH gene expression without 142 
confounding variables that may be present in in vivo studies. Here, we combine in vivo 143 
mouse studies and investigate the direct effects of cytokines on GnRH gene expression 144 
in GT1-7 cells. Our results delineate the molecular mechanisms and signaling pathways 145 
that LIF activates and strongly suggest that LIF directly affects GnRH neurons to 146 
regulate GnRH gene expression in infection or obesity induced inflammation of the 147 
hypothalamus.  148 
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 149 
Materials and Methods  150 
Animals 151 
 C57BL/6J mice were maintained under a 12-h light, 12-h dark cycle and received food 152 
and water ad libitum. All experiments were performed with approval from the University 153 
of California (Riverside, CA) Animal Care and Use Committee and in accordance with 154 
the National Institutes of Health Animal care and Use Guidelines. C57BL/6J male mice 155 
were placed on either a high fat diet (HFD, D12492, 60% kcal from fat; 5.21 kcal/g;  156 
protein 20% kcal; fat 60% kcal (lard 0.32 g/g diet, soybean oil 0.03 g/g); carbohydrate 157 
20% kcal;  Research Diet, New Brunswick, NJ) or control diet (CTR, D12450J, 10% kcal 158 
from fat; matching sucrose levels to HFD; 3.82 kcal/g; protein 20% kcal; fat 10% kcal 159 
(lard 0.02 g/g diet, soybean oil 0.025 g/g); carbohydrate 70% kcal; Research Diet, New 160 
Brunswick, NJ) from weaning age for 12 weeks. Mice treated with vehicle or LPS were 161 
fed standard food pellets (STD, 5053, 4.07 kcal/g; protein 24% kcal; fat 13%; 162 
carbohydrates 63%; St. Louis, MO) from weaning. Lipopolysaccharide (LPS, 2.5 mg/kg 163 
body weight) from Escherichia coli (catalog # L4391, Sigma, USA) was administered by 164 
intraperitoneal injection. Mice were sacrificed 24 h post LPS treatment in parallel with 165 
the corresponding control groups. At least 10 animals/diet or treatment were analyzed 166 
unless otherwise indicated, and differences from corresponding controls were compared 167 
by Student’s t test. GnRH-GFP mice were kindly provided by Dr. Suzanne Moenter [64] 168 
to facilitate investigation of fluorescently labeled GnRH neurons. 169 
 170 
 171 
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Histological Analysis and Immunohistochemistry  172 
For brain collection, animals were perfused with ice cold phosphate buffer saline (PBS) 173 
solution followed by 4% paraformaldehyde solution. Brains were post-fixed in 4% 174 
paraformaldehyde 2 h at room temperature and cryopreserved in 30% sucrose/PBS 175 
solution for 3 days at 4°C before freezing in OTC. Frozen brains from GnRH-GFP mice 176 
were sectioned to 30 μm sections and stained for GFP to visualize GnRH neurons and 177 
for GP130 or cFOS. Slides were blocked with 20% goat serum and incubated with 178 
primary antibodies against GFP (1:5000 raised in chicken, Table 1) at 4°C for 48 h. 179 
After PBS washes, slides were incubated with FITC/Alexa 488 goat anti-chicken IgG 180 
(1:300, Molecular Probes, Eugene, OR) for 1 h. Slides were then incubated with primary 181 
antibodies against GP130 (1:500, MAB4681, R&D Systems, Minneapolis, MN) or cFOS 182 
(1:300, SC-52, Santa Cruz Biotechnology, Inc. Dallas, TX) for 48 h at 4°C followed by 183 
Alexa 594 goat-anti-rat IgG (1:300, Molecular Probes, Eugene, OR)  or biotinylated goat 184 
anti-rabbit IgG (1:300; Vector Laboratories, USA) and Cy5-streptavidin (1:300, 434316, 185 
Life Tech. Corp. Eugene, OR) for 1 h each at room temperature, respectively. Sections 186 
were mounted and slides covered using VectaSheild mounting media with DAPI (H-187 
1500, Vector Laboratories, USA). Secondary antibody-only controls were performed to 188 
determine antibody specificity. Images were obtained using a Leica microscope system.  189 
To quantify the number of cFOS expressing GnRH neurons, coronal sections of 190 
the preoptic area in the hypothalamus of GnRH-GFP mice were stained for GFP (green) 191 
and cFOS (red). Three hundred GnRH-GFP neurons from each of the four male mice 192 
from control and HFD group were counted for the co-labeling with cFOS and results 193 
represented as a percent of total GFP labeled neurons. To assess expression of cFOS 194 
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in other cells, two 100 µm x 100 µm areas, one area proximal to the organum 195 
vasculosum of the lamina terminalis (OVLT) and one more dorsal, in the same section 196 
were counted to quantify the number of cFOS expressing cells, where DAPI staining 197 
was used to identify cell nuclei. Statistical differences (p < 0.05) were determined by 198 
Student’s T-test. 199 
 200 
qPCR Analysis 201 
Hypothalami were dissected, total RNA extracted using MicroRNA kit from Ambion and 202 
reverse transcribed using Superscript III (Invitrogen, CA). qPCR was performed using 203 
an iQ SYBR Green supermix and an IQ5 real-time PCR machine (Bio-Rad Laboratories, 204 
Hercules, CA), with primers listed in Table 2, under the following conditions: 95 ºC for 205 
15 min, followed by 40 cycles at 95 ºC for 20 s, 56 ºC for 30 s, and 72 ºC for 30 s. The 206 
amount of the gene of interest was calculated by comparing the threshold cycle 207 
obtained for each sample with the standard curve generated in the same run and 208 
normalized to the beta-2-microglobulin (B2M) housekeeping gene in the same sample 209 
using ∆∆Ct method. Replicates were averaged. After each run, a melting curve analysis 210 
was performed to confirm that a single amplicon was generated in each reaction. 211 
Statistical differences (p < 0.05) in expression were determined by Student’s T-test 212 
using JMP software (SAS Institute; Cary, North Carolina). 213 
 214 
Cell Culture  215 
GT1-7 cells, kindly provided by Pamela Mellon (University of California, La Jolla, CA), 216 
were cultured in DMEM (Cellgro, Mediatech, Inc., Herndon, VA) with 10% FBS. 217 
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Leukemia Inhibitory Factor (LIF, 34-8521; eBioscience, USA) and interleukin 6 (IL-6, 218 
216-16, PeproTech, Rocky Hill, NJ) were reconstituted in PBS containing 0.1% BSA 219 
and stored in aliquots at -80°C until use. RNA was isolated with TRIzol (Life Tech. 220 
Carlsbad, CA) and RT-PCR performed as previously described [65, 66].  221 
 222 
Western Blot Analysis             223 
Whole cell lysates were obtained after treatment with 10 ng/mL LIF or vehicle for times 224 
indicated, using lysis buffer (20 mM Tris-HCl, pH 7.4, 140 mM NaCl, 0.5% Nonidet P-225 
40, 0.5 mM EDTA) with 1% protease inhibitor cocktail (P8340, Sigma, USA) and 1 mM 226 
PMSF. Protein content was determined using Bradford reagent (Bio-Rad Laboratories 227 
Inc. USA). An equal amount of protein from each sample was resolved on a 10% SDS-228 
PAGE and electrotransferred to a nitrocellulose membrane. Membranes were blocked 229 
in TBST (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween-20) with 10% non-fat milk 230 
for 2 h room temperature and incubated overnight with specific antibodies for p-STAT3 231 
(1:1000; 9134, Cell Signaling, Danvers, MA), STAT3 (1:1000, 9139, Cell Signaling, 232 
Danvers, MA), p-p38 (1:1000, 9211, Cell Signaling Danvers, MA), p38 (1:1000, 9212, 233 
Cell Signaling Danvers, MA), p-ERK1/2 (1:1000, 9101, Cell Signaling, Danvers, MA), 234 
ERK1/2 (1:1000, 9102, Cell Signaling, Danvers, MA), p-JNK (1:1000, 9255, Cell 235 
Signaling, Danvers, MA), JNK (1:1000, 9252, Cell Signaling, Danvers, MA), OCT-1 236 
(1:500, ab66132, Abcam, Cambridge, UK), cFOS (1:1000, SC-52, Santa Cruz 237 
Biotechnology, Inc. Dallas, TX), and β-tubulin (1:1000, SC-9104, Santa Cruz 238 
Biotechnology, Inc., Dallas, TX). The bands were visualized with horseradish 239 
peroxidase (HRP)-linked secondary antibodies and enhanced chemiluminescence 240 
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reagent (ECL; Amersham Bioscience), as described by manufacturer. Blots were 241 
exposed to autoradiography film (Bioexpress, USA). Each experiment was performed 3 242 
times and representative images are presented. 243 
 244 
Transfections 245 
Cells were plated into 12-well plates and transfected using Fugene 6 reagent (Roche 246 
Applied Science), as described previously [66-69]. Wells were transfected with 500 ng 247 
of reporter plasmid, 100 ng of β-galactosidase reporter plasmid driven by the 248 
Herpesvirus thymidine kinase promoter, as an internal control for the efficiency of the 249 
transfection, and 200 ng of expression vectors or empty vector control, as indicated in 250 
the figure legends. 24 h after transfection, cells were switched to serum-free media 251 
(DMEM with 0.1% BSA) and treated with either 10 ng/mL LIF, 20 ng/mL IL-6 or vehicle 252 
for 24 h. Following treatment, cells were lysed in 0.1 M potassium phosphate buffer, pH 253 
7.8, with 0.2% Triton X-100. Luciferase activity in the lysates was measured with a 254 
Veritas Microplate luminometer (Turner Biosystems, Sunnyvale, CA) after injection with 255 
100 µL of luciferase assay buffer (100mM Tris-HCl, pH 7.8, 15 mM MgSO4, 10 mM 256 
ATP, and 65 µM luciferin). β-galactosidase activity was measured using the Tropix 257 
Galacto-light β-galactosidase assay (Applied Biosystems, Foster City, CA). All 258 
experiments were performed three independent times and in triplicates within each 259 
experiment. Luciferase values were normalized to β-galactosidase values for each 260 
sample. Results are presented as an average of three experiments. Statistical 261 
significance, p < 0.05, was determined with ANOVA followed by Tukey’s post hoc test 262 
using JMP software (SAS Institute; Cary, North Carolina). 263 
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 264 
Plasmids 265 
The reporter plasmids were kindly provided by Pamela Mellon (University of California, 266 
La Jolla, CA). The -5 kb rat GnRH (-4984 to +22 relative to the transcription start site); 267 
GnRH E/P, which contains GnRH-E1 (-1863 to -1571)/GnRH-P (-173 to +112); and 268 
GnRH-P (-173 to +112) luciferase reporters have previously been described [70-73]. 269 
Luciferase reporter plasmids containing mutations of AP1 binding site in GnRH 270 
enhancer and GnRH promoter, and reporter plasmids with RSV promoter fused to 271 
GnRH enhancer (GnRHe/RSVp), have also been previously described [70-73]. The 272 
expression vectors for wild type (WT) STAT3 (Stat3 Flag pRC/CMV, #8707, Addgene, 273 
Cambridge), dominant negative (DN) STAT3 (Stat3 Y705F Flag pRC/CMV, #8704, 274 
Addgene, Cambridge), constitutively active (CA) STAT3 (Stat3-C Flag pRC/CMV, 275 
#8722, Addgene, Cambridge), and luciferase reporter containing STAT3 response 276 
element (SBR, 4xM67 pTATA TK-Luc, #8688, Addgene, Cambridge, MA) were 277 
purchased from Addgene and have previously been described [74].  Expression vectors 278 
for constitutively active RAS, MEK1, MEK2, MKK4, MKK7, MKK3, MKK6, and 279 
constitutively active isoforms of p38 (p38α, p38β, p38λ, p38δ) were a gift from Peiqing 280 
Sun (The Scripps Research Institute, La Jolla, CA) [75]. Expression vector for cFOS has 281 
been previously described [65, 76-78]. 282 
 283 
 284 
 285 
 286 
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Results 287 
Inflammation in the hypothalamus induces inflammatory cytokines and represses 288 
GnRH.  289 
Inflammation, either acute, caused by an injection of lipopolysaccharide (LPS), or 290 
chronic, elicited by high fat diet (HFD), negatively affects hypothalamic neurons and in 291 
particular, reproductive function [21, 79]. We and others postulated this impairment is 292 
due to repression of the GnRH gene, which is the final brain signal in the control of 293 
reproduction. Inflammatory cytokines have previously been proposed to negatively 294 
regulate GnRH neurons [16, 18, 80].  We initiated our studies with an analysis of 295 
cytokine mRNA levels in the hypothalami of C57BL/6J male mice, induced by LPS 296 
injection, a bacterial endotoxin known to elicit an inflammatory response. Our studies 297 
revealed that tumor necrosis factor alpha (TNF-α, Tnf) mRNA was induced 22-fold, 298 
interleukin 1 beta (IL-1β, Il1b) was induced 7-fold, IL-6 (Il6) 1.6-fold, and leukemia 299 
inhibitory factor (LIF, Lif) 2.2-fold after LPS injection (Fig. 1A). Gnrh mRNA level in mice 300 
treated with LPS was reduced by 72% (Fig. 1A).  301 
Obesity is considered a state of chronic inflammation as opposed to acute 302 
inflammation elicited by LPS injection [24, 25, 81]. Thus, we exposed male C57BL/6J 303 
mice to HFD or to control diet (CTR) for 12 weeks. Diet-induced obesity induced TNF-α 304 
1.6-fold and IL-1β 1.7-fold, although due to variability, it did not reach significance (Fig. 305 
1B). IL-6 was significantly induced 3.1-fold and LIF 1.6-fold, compared to mice fed CTR 306 
diet (Fig. 1B). Further analysis revealed significantly reduced Gnrh mRNA levels by 307 
46%, compared to the controls (Fig. 1B). Thus, increase in locally produced cytokines, 308 
acute and chronic, correlates with repression of GnRH mRNA expression.  309 
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LIF represses GnRH  310 
We then determined whether these locally produced, inflammatory cytokines can 311 
regulate GnRH gene expression directly. Due to the scarcity and scattered location of 312 
GnRH neurons in mice, in vivo analysis of molecular mechanisms whereby cytokines 313 
regulate GnRH gene is not possible. To analyze direct effects of cytokines on gene 314 
expression we employed GT1-7 cells that are an established Gnrh expressing and 315 
GnRH secreting cell model [62]. We expressed GnRH 5 kb luciferase reporter (5 kb 316 
GnRH luc) in GT1-7 cells and treated with inflammatory cytokines. LIF repressed GnRH 317 
reporter expression by 45.7% compared to CTR (Fig. 2A, black bar), similar to what was 318 
observed in vivo with LPS injection and HFD. TNF-α, IL-1β and IL-6 had no effect on 319 
GnRH expression. To further analyze the effect of LIF treatment on GnRH gene, RNA 320 
was isolated from GT1-7 cells treated with either vehicle or LIF, reverse transcribed and 321 
quantitative RT-PCR performed. LIF treatment reduced endogenous GnRH mRNA 322 
levels by 39.1% (Fig. 2B).  Taken together, these results indicate that LIF represses 323 
Gnrh gene.  324 
Since LIF and IL-6 belong to the same cytokine family, it was surprising that LIF 325 
repressed GnRH while IL-6 did not. These two cytokines share GP130 signaling 326 
receptor, but each has a specific receptor for ligand binding. We analyzed the 327 
expression of their specific receptors on GnRH neurons to explain why IL-6 had no 328 
effect on GnRH gene expression. We first demonstrated the expression of GP130 329 
cytokine signaling receptor (red) on GnRH neurons (green) in vivo using 330 
immunocytochemistry of hypothalamic slices (Fig. 3A). This suggests that LIF and IL-6 331 
cytokines can act on GnRH neurons in the mouse.  Since antibodies for specific LIF 332 
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receptor (LIFR) and IL-6 receptor (IL-6R) were not effective in immunohistochemistry, 333 
we analyzed mRNA expression of these receptors using RNA isolated from GT1-7 cells. 334 
Products of expected size for GP130 (177 bp), and  LIFR (452 bp), were present in both 335 
GT1-7 cells and spleen, which served as a positive control, but absent in negative 336 
control samples lacking reverse transcriptase (Fig. 3B). IL-6R expression (156 bp) was 337 
absent in GT1-7 cells, but present in spleen (Fig, 3B). qPCR analysis reveals that the 338 
expression of IL-6R is limited in GT1-7 cells, compared to the expression of GP130 and 339 
LIFR, while expression levels of these receptors was similar in spleen (Fig. 3C). These 340 
results indicate that LIF can directly bind GnRH neurons and affect GnRH gene 341 
expression. 342 
 343 
LIF functions via GnRH enhancer to repress GnRH gene 344 
The 5 kb GnRH reporter contained two upstream regulatory elements: the 300 bp 345 
enhancer (−1863 to −1571) and the evolutionarily conserved promoter (−173 to +1), that 346 
confer neuron-specific activation of the GnRH, in culture and in vivo [70, 82, 83]. To 347 
map the elements necessary for LIF mediated repression of GnRH expression, GT1-7 348 
cells were transiently transfected with a luciferase reporter containing the 5 kb 349 
regulatory region upstream of the GnRH transcription start site (5 kb GnRH), a reporter 350 
containing the enhancer and promoter without intervening sequences (GnRH E/P) or a 351 
reporter containing the promoter (GnRH P). LIF repressed luciferase activity of the 5 kb 352 
GnRH reporter and of the reporter containing the enhancer and promoter, GnRH E/P 353 
luc, by 45.7% and 42.6% respectively (Fig. 4A and 4B). Luciferase activity of the 354 
reporter containing only the promoter, GnRH P luc, did not change in response to LIF 355 
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(Fig. 4C). Next, to examine if the enhancer is sufficient for repression, the reporter 356 
containing enhancer fused to heterologous RSV promoter was examined (GnRH 357 
E/RSVp luc). LIF treatment significantly repressed GnRH E/RSVp luc reporter by 45.2% 358 
(Fig. 4D). Given that GnRH E/P and GnRH E/RSVp reporters were repressed to a 359 
similar degree by LIF as the full length 5 kb GnRH reporter, these results indicate that 360 
the enhancer is sufficient and necessary for repression by LIF.  361 
 362 
STAT3 is not necessary for GnRH repression by LIF 363 
LIF signals through GP130 to activate the signal transducer and activator of 364 
transcription (STAT) pathway. To analyze signaling pathways activated by LIF, cells 365 
were treated with LIF and western blots performed using whole cell lysate. LIF 366 
treatment resulted in increased levels of STAT3 phosphorylation (Fig. 5A). To determine 367 
whether STAT3 is sufficient to repress GnRH gene expression, GT1-7 cells were co-368 
transfected with a constitutively active STAT3 mutant (CA STAT3) and STAT binding 369 
region (SBR), a reporter containing 6 copies of the STAT3 response element that 370 
serves as a positive control; or with GnRH E/P reporter. CA STAT3 overexpression 371 
induced STAT3-SBR to the similar level as induction by LIF. LIF treatment together with 372 
CA STAT3 overexpression did not further increase induction over CA STAT3 alone, 373 
indicating that CA STAT3 maximally induces SBR reporter.  On the other hand, CA 374 
STAT3 overexpression did not affect the expression of the GnRH E/P reporter or its 375 
repression by LIF (Fig. 5B). We then analyzed necessity of STAT3 by co-transfecting 376 
dominant negative mutant STAT3 (DN STAT3) with SBR or with GnRH E/P. While 377 
transfection with DN STAT3 inhibited LIF induction of SBR positive control, DN STAT3 378 
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did not prevent repression of GnRH E/P by LIF (Fig. 5C). Taken together, these results 379 
demonstrate that STAT3 is not necessary for GnRH repression by LIF.  380 
 381 
LIF activates p38 to repress GnRH 382 
LIF signaling has been shown to activate the mitogen activated protein kinase 383 
(MAPK) pathway, which include extracellular signal-regulated protein kinases (ERK1/2), 384 
p38, and the c-Jun N-terminal kinases (JNK) in a variety of other cells, including mouse 385 
embryonic stem cells, 3T3-L1, and AtT20 pituitary corticotrope cells [84, 85]. LIF 386 
treatment of GT1-7 cells resulted in phosphorylation of ERK1/2 and p38, but no 387 
changes in JNK phosphorylation were observed (Fig. 6A). To further delineate the 388 
necessity of MAPK signaling pathway, co-transfection assays with expression plasmid 389 
containing constitutively active RAS (CA RAS), that is upstream to the MAPK pathway, 390 
resulted in repression of GnRH expression by 51.4% (Fig. 6B). To identify the MAPK 391 
kinase pathway sufficient for repression, co-transfection assays were conducted using 392 
constitutively active forms of MEK1 and MEK2 that leads to ERK1/2 activation, MKK3 393 
and MKK6 that that activate p38, or MKK4 and MKK7 which activates JNK. 394 
Constitutively active MEK1, MEK2, MKK4, MKK7 had no effect on GnRH expression. 395 
GnRH expression was repressed with constitutively active MKK3 and MKK6, which lead 396 
to activation of p38, by 40.9% and 48.2% respectively (Fig. 6C).  397 
The p38 kinases have four isoforms, p38α, p38β, p38γ, and p38σ [86]. To 398 
explore the role of these isoforms on GnRH, constitutively active mutants of p38 399 
isoforms were analyzed in co-transfection assays. Reporter activity was repressed by 400 
31% with constitutively active p38α, while overexpression of constitutively active p38β, 401 
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p38γ, and p38σ, had no effect on luciferase activity (Fig. 6D). These results 402 
demonstrate that LIF represses GnRH transcriptional activity via the MAPK pathway, 403 
specifically p38, and highlights the important role that p38α plays in this repression.  404 
 405 
cFOS is induced by LIF in GT1-7 cells and represses GnRH  406 
OCT-1 has been previously identified as an essential regulator of GnRH gene 407 
transcription [87]. Western blot analysis revealed that OCT-1 protein level was not 408 
affected by LIF treatment in GT1-7 cells, suggesting that OCT-1 may not mediate LIF 409 
repression of the GnRH gene. GnRH gene repression by cFOS has previously been 410 
shown [72], and thus we next examined cFOS protein levels. Indeed, western blots 411 
demonstrated that cFOS was induced by LIF (Fig. 7A). GnRH E/P reporter was 412 
repressed by 43.4% with overexpression of cFOS (Fig. 7B). This indicates that induction 413 
of cFOS is likely mediating LIF repression of GnRH. 414 
Several cFOS binding sites were previously identified in the GnRH regulatory 415 
region [71-73]. To identify the site involved in LIF repression of GnRH, GT1-7 cells were 416 
transfected with luciferase reporters containing mutation of the putative cFOS sites at -417 
79 in the promoter region (-79m), -1723 (-1723m), -1782 (-1782m), and -1793 (-1793m) 418 
in the enhancer and their expression was compared to wild type GnRH E/P (WT). LIF 419 
repressed luciferase activity of all reporters used by 61.0%, 61.8%, 65.9%, and 61.6% 420 
respectively, except of the -1793 mutant, indicating that the mutation of this site 421 
prevents LIF repression of GnRH (Fig. 7C). Thus, the -1793 site is involved in LIF 422 
repression of GnRH. We confirmed the role of this site by transfecting the mutation of 423 
the -1793 site in the GnRH E/RSVp reporter and comparing the repression of the 424 
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mutant to the wild-type reporter containing the GnRH enhancer linked to the RSV 425 
promoter (GnRH E/RSVp). Similar to what was observed in Fig. 7C, LIF repression of 426 
GnRH was inhibited with a mutation of the -1793 site (Fig. 7D). Therefore, LIF induces 427 
cFOS which represses GnRH gene expression via the -1793 site. 428 
 429 
cFOS expression is induced with HFD in mice 430 
 Since we determined that cFOS mediates LIF repression of the GnRH gene and 431 
we observed reduced GnRH mRNA levels in the hypothalami of mice fed HFD, we 432 
explored cFOS expression in the hypothalamus. We concentrated specifically in the 433 
sections containing the OVLT where the largest numbers of GnRH neuron soma are 434 
found. In the hypothalamus of GnRH-GFP mice fed HFD, a significant increase in the 435 
percent of double labeled green GnRH neurons with cFOS (red) was observed 436 
compared to control (CTR) (Fig. 8A and 8B.1). In CTR fed mice, 17.9% of GnRH 437 
neurons expressed cFOS, while in the HFD mice, 36.3% of GnRH neurons expressed 438 
cFOS, suggesting that HFD induces cFOS expression in GnRH neurons. To examine 439 
specificity of this increase, we also counted cells that express cFOS in two other areas, 440 
one proximal to OVLT and one more dorsal from OVLT, using DAPI to identify cell 441 
nuclei. We determined that there is an increase in the percent of cFOS positive neurons 442 
in the area proximal to the OVLT of mice fed HFD (45.4%) compared to CTR (30.5%) 443 
(Fig. 8A.2, 8B.2). However, in the area dorsal to OVLT, we did not observe a difference 444 
in the number of neurons that express cFOS (Fig. 8B.3). Thus, obesity induces cFOS 445 
expression in neurons in the proximity to OVLT and in GnRH neurons. Given that cFOS 446 
mediates LIF repression of the GnRH gene in GT1-7 cells, and the reduced levels of 447 
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GnRH mRNA observed in vivo coupled with an increased cFOS expression in GnRH 448 
neurons following LIF induction by inflammatory stimuli, our data together demonstrate 449 
that LIF represses Gnrh mRNA in vivo through cFOS. Furthermore, LIF may mediate 450 
repression of the Gnrh mRNA and reproductive function caused by inflammation.  451 
 452 
Discussion 453 
 454 
 455 
Both infection and obesity negatively affect hypothalamic function, GnRH 456 
neuronal network and reproduction, but the mechanisms are unknown. We postulated 457 
that neuroinflammation is a common characteristic between these conditions and that 458 
inflammatory cytokines may mediate impairment of reproductive function by both 459 
infection and obesity. Classical pro-inflammatory cytokines, TNF-α, IL1β, and IL-6, are 460 
induced in the brain during inflammation, when GnRH and LH expression and secretion 461 
are diminished, but direct regulation of GnRH neuron function by cytokines remain 462 
inconclusive. In our recently published report [24] and herein, we identified a novel 463 
cytokine, leukemia inhibitory factor (LIF), which is induced during these inflammatory 464 
states that directly affects GnRH gene expression. In this report, we also determined the 465 
precise mechanisms of GnRH gene repression and signaling pathways that are 466 
necessary for LIF-mediated effects on GnRH neurons. Finally, we demonstrated that 467 
the transcription factor induced by LIF to repress GnRH gene is increased in a location 468 
specific manner following HFD in vivo.  469 
Repression of Gnrh mRNA expression is consistently observed during 470 
inflammatory states.  In agreement with previous reports, acute inflammation, elicited 471 
with an injection of LPS and chronic inflammation, caused by high fat diet (HFD)-472 
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induced obesity, suppresses GnRH mRNA in our studies. LPS treatment, resulting in 473 
inflammation, represses Gnrh in ewes [88], birds [89] and rats [90]. Infusion of the pro-474 
inflammatory IL-1β cytokine into the rodent hypothalamus also represses Gnrh 475 
expression [16]. We and others reported that obese mice fed HFD, with a low grade 476 
chronic inflammation, exhibit lower Gnrh mRNA [24, 91, 92]. These reports suggested 477 
that repression of Gnrh mRNA during inflammation may be a result of increased 478 
cytokine concentration. Alternatively, microglia, brain resident immune cells, are 479 
involved in the regulation of synaptic transmission and activity-dependent structural 480 
remodeling [93]. In neuroinflammation, in response to injury, infection, or disease, 481 
microglia engulf damaged synapses [93]. We demonstrated decreased synaptic spine 482 
density in GnRH neurons following obesity-mediated neuroinflammation and microglia 483 
activation, indicating reduced connectivity [24]. This reduced synaptic activity may 484 
regulate Gnrh expression in an activity-dependent manner [94, 95]. Some synaptic 485 
proteins are regulated in an activity-dependent manner at the transcriptional level [96]. 486 
This may be the case with GnRH gene expression as well, since several hypothalamic 487 
factors, such as RFamide-related peptide 3 (RFRP-3), a mammalian gonadotropin-488 
inhibitory hormone ortholog; senktide, a neurokinin B receptor agonist; and oxytocin; 489 
alter both GnRH secretion and Gnrh transcription [97-99]. However, since GnRH 490 
neurons express cytokine receptors [27], herein, we investigated if Gnrh gene is 491 
repressed via activation of cytokine receptor signaling pathways. 492 
We identified LIF as a critical player in the neuroinflammation-induced 493 
impairment of GnRH gene expression. In the brain, LIF is involved in neural stem cell 494 
maintenance and axonal growth, and in modulation of gene expression [100]. During 495 
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embryonic development, LIF is expressed in the olfactory placode, which led to the 496 
hypothesis that LIF affects GnRH neuron migration [54]. Our results demonstrate that 497 
LIF represses GnRH gene expression, which is in agreement with findings that GnRH 498 
mRNA is repressed during embryonic GnRH neuron migration [101], in addition to 499 
repression during inflammation. To analyze the effects of infection on GnRH, previous 500 
studies analyzed classical inflammatory markers, TNF-α, IL-1β and IL-6, but not LIF. 501 
Although LPS, or TNF-α or IL-1β administration in the ventricle consistently reduces 502 
GnRH secretion in vivo [18, 20, 21, 23], some have found that IL-6 treatment of the 503 
hypothalamic slices stimulates GnRH secretion [19, 102]. While IL-1β and TNF-α are 504 
prototypical pro-inflammatory cytokines, IL-6 may function as either a pro- or anti-505 
inflammatory cytokine depending on timing and stimulus. IL-6 synthesis in the 506 
hypothalamus is induced by IL-1β [103], and IL-6 may be engaged in the negative 507 
feedback to dampen inflammation [42]. Thus, results may vary due to the differences 508 
between in vivo and in vitro treatments, since initially-induced cytokines may cause a 509 
cascade of other cytokines in vivo. For this reason, we concentrated on analyzing the 510 
effects of LIF in GT1-7 cells. LIF alone repressed Gnrh mRNA and GnRH reporter, 511 
similarly to HFD-induced and LPS-elicited repression of GnRH mRNA in vivo.  LIF is 512 
induced by IL-1β in vivo.  Therefore, IL-1β repression of GnRH mRNA, demonstrated in 513 
previous studies, may occur via induction of LIF.  514 
We determined that LIF induces cFOS which represses GnRH gene expression. 515 
GnRH repression by cFOS has been demonstrated previously and several cFOS 516 
binding sites have been identified in the GnRH regulatory region [72, 73]. However, a 517 
specific site necessary for GnRH repression has not been identified, until now. GnRH 518 
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gene is inhibited by PKC signaling pathway, which induces cFOS [70, 104]; and PKC 519 
activation by TPA treatment represses GnRH gene via the -1793 site [71]. Here we 520 
demonstrate that this same site at -1793 is involved in LIF repression of the GnRH 521 
gene. This site is juxtaposed to the OCT-1 binding site, and OCT-1 is the critical 522 
transcription factor that regulates GnRH gene expression [71, 87, 105, 106]. Thus, 523 
although OCT-1 protein levels do not change with LIF treatment, its interaction with 524 
cFOS [107], likely modulates that level of GnRH gene expression. 525 
Signaling pathways involved in the regulation of GnRH gene transcription by 526 
cytokines have not been elucidated. GP130, the common signal transducer for IL-6 and 527 
LIF family, is expressed in GnRH neurons in vivo. LIF treatment activates STAT3 in 528 
GT1-7 cells, a model of mature GnRH neurons, as we show herein, and in GN11 cells, 529 
a model of immature, migrating GnRH neurons [54]. However, STAT3 does not play a 530 
role in GnRH gene repression. To exert its effect on GnRH gene expression, LIF 531 
activates MAPK-p38 pathway, and in particular p38α is critical for repression. This is an 532 
important finding, since while other p38 isoforms have normal physiological functions, 533 
p38α is involved in inflammatory processes [108]. Moreover, p38α is the target for 534 
several potential therapeutics for chronic inflammatory disorders.  535 
Leptin is necessary for pubertal transition and normal reproductive function [109-536 
111]. Since leptin is elevated in obese and HFD-fed mice, leptin was previously 537 
analyzed as a mediator of obesity-induced impairment of reproductive function [10, 112-538 
114]. Additionally, a mouse model with leptin overexpression exhibits early puberty and 539 
lower GnRH at 21 weeks of age [115], which may correlate with precocious puberty in 540 
obese girls and lower Gnrh mRNA in obese mice in our study. However, previous 541 
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studies determined that leptin does not directly affect GnRH neurons in vivo, since 542 
deletion of the leptin receptor specifically in GnRH neurons had no effect on fertility 543 
[116]. STAT3 signaling molecule that is activated by leptin, is required for leptin’s role in 544 
energy balance, but is not required for leptin’s effect on fertility [117, 118]. STAT3 545 
studies demonstrate separate roles for leptin signaling pathways, involved in metabolic 546 
function that require STAT3, and reproductive function that do not. Although leptin 547 
receptor is similar to the IL-6 and LIF signaling receptor, GP130, and can activate the 548 
same signaling pathways, leptin does not engage GP130 [119]. Given that in vivo 549 
studies determined that leptin influences reproductive function via its actions in the 550 
brain, but indirectly, via GnRH neuron afferents, it is unlikely that elevated leptin levels 551 
in our studies had direct effects on GnRH gene expression. 552 
We demonstrate that cFOS expression is increased specifically in GnRH neurons 553 
and in cells located close to the OVLT, but not in cells located more dorsally, following 554 
HFD. Others reported increased cFOS following HFD in specific areas and postulated 555 
that the location is specific for the function of the neuronal population. For example, 556 
cFOS was increased in the reward circuitry following HFD [120] and in the dorsomedial 557 
and lateral hypothalamus [121]. cFOS is similarly induced following LPS treatment in 558 
the hypothalamus [122] and this induction is location specific [123]. These studies 559 
further postulated that the location is dependent on the function of the neurons. We, on 560 
the other hand, posit that it is dependent on the proximity to the vasculature. Previous 561 
studies also suggested that cFOS was induced following neuron activation, since cFOS 562 
is most commonly used marker of neuronal activity. As an immediate early gene, cFOS 563 
is induced via activity-dependent transcription in neurons. cFOS expression is increased 564 
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in activated GnRH neurons, during the preovulatory LH surge and after kisspeptin 565 
treatment [124, 125]. The roles of cFOS as a transcription factor, involved in the GnRH 566 
gene regulation, and as a marker of neuronal activity, are not mutually exclusive. Thus, 567 
we postulate that increased LIF concentration induces cFOS in GnRH neurons to 568 
repress GnRH gene expression. Specificity for GnRH neurons may be due to either 569 
their proximity to the OVLT or because GnRH processes extend beyond the blood brain 570 
barrier into the OVLT.  571 
Our studies delineate the mechanisms of neuroinflammation impairment of 572 
GnRH gene expression, and may explain repression of reproductive function during 573 
infection and in obesity. We identified LIF as the cytokine that mediates these effects 574 
and p38α as a critical signaling molecule. We also postulate that the proximal location 575 
of GnRH neurons to the leaky blood brain barrier, where the local concentration of this 576 
cytokine may be the highest, permits for repression of GnRH gene expression via cFOS 577 
induction. Future studies will determine in vivo role of p38α in neuroinflammation-578 
mediated GnRH repression.  579 
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 990 
 991 
Figure Legends 992 
 993 
1. GnRH expression is repressed when cytokine levels are increased.  A, 994 
Hypothalami from male mice 24 hours after injection with either vehicle control (CTR, 995 
white bars) or lipopolysaccharide (LPS, gray bars). B, Hypothalami from male mice 996 
following 12-week feeding with control (CTR, white bars) or high fat diet (HFD, black 997 
bars). Cytokine and GnRH (Gnrh1) expression was assayed with RT-qPCR. TNF-α, 998 
(Tnf) tumor necrosis factor alpha; IL-1β, (Il1b) interleukin 1 beta; IL-6, (Il6) interleukin 6; 999 
LIF, (Lif) leukemia inhibitory factor. * indicates significant difference (p<0.05) determined 1000 
with t-test.  1001 
 1002 
2. GnRH expression is suppressed by LIF. A, GT1-7 cells transiently transfected with 1003 
5 kb GnRH-reporter (5 kb GnRH Luc) treated with vehicle (CTR, white bar), or TNF-α, 1004 
IL-1β, IL-6, LIF, for 24 hours. Luciferase values were normalized to β-galactosidase 1005 
values for each sample. Results are presented as an average of three experiments 1006 
performed in triplicate. Statistical significance (p < 0.05) was determined with ANOVA 1007 
followed by Tukey’s post hoc test, and indicated with *. B, RT-qPCR using total RNA 1008 
from GT1-7 cells treated with LIF, 10 ng/mL for 24h, demonstrates repression of 1009 
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endogenous GnRH mRNA (Gnrh1). * indicates significant difference determined with 1010 
t-test (p<0.05). 1011 
 1012 
3. GP130 is expressed in GnRH neurons in vivo and in GT1-7 cells. A, 1013 
Immunohistochemistry of GnRH neurons genetically labeled with GFP (green), stained 1014 
for GP130 receptor (red). Bar indicates 25µm. White arrows indicate GnRH neurons 1015 
that express GP130, while arrowheads indicate GP130 staining in non-GnRH cells. B, 1016 
RT-PCR demonstrates expression of GP130 (177 bp) and LIFR (452 bp), but not IL-6R 1017 
(156 bp) in GT1-7 cells (RT+), while all three receptors are expressed in the spleen (S). 1018 
RT-, GT1-7 cells mRNA used without reverse transcriptase serves as negative controls; 1019 
L, size ladder. C, RT-qPCR demonstrates relative expression of GP130, LIFR, IL-6R in 1020 
GT1-7 cells and the spleen.  1021 
 1022 
4. LIF represses GnRH gene expression through the enhancer region. A, 5 kb 1023 
GnRH reporter containing 5 kb of the GnRH gene regulatory sequence from the 1024 
transcriptional start site; B, reporter containing GnRH enhancer (E, -1863/-1571) and 1025 
promoter (P, −173/+1); C, reporter containing GnRH promoter -173/+1 (P) and D, 1026 
reporter containing GnRH enhancer (E, -1863/-1571) linked to the heterologous RSV 1027 
(Raus Sarcoma Virus) promoter (GnRH E/RSVp luc); were transfected in GT1-7 cells 1028 
and cell treated with LIF for 24h. Results demonstrate sufficiency of the enhancer for 1029 
GnRH repression by LIF. Statistical significance, p < 0.05, indicated with *, was 1030 
determined with a t-test. 1031 
 1032 
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5. STAT3 is not sufficient or necessary for GnRH repression by LIF. A, Analysis of 1033 
STAT3 phosphorylation by western blot of GT1-7 cell lysates after 10 ng/mL LIF 1034 
treatment, for 10, 30 and 120 minutes. B, Co-transfection of a reporter containing 6 1035 
copies of the STAT3 response element (SBR) or GnRH E/P with a constitutively active 1036 
(CA) STAT3 demonstrates that CA-STAT3 is sufficient to induce SBR, but not GnRH 1037 
E/P. C, Co-transfection of a dominant negative (DN) STAT3 inhibits LIF induction of 1038 
SBR-luciferase, but does not prevent LIF repression of the GnRH E/P reporter. 1039 
Statistical significance (*, p < 0.05) was determined with ANOVA followed by Tukey’s 1040 
post hoc test. 1041 
 1042 
6. p38α is sufficient to repress GnRH gene expression. A, LIF treatment activates 1043 
ERK1/2, p38, but not JNK, demonstrated by western blots using whole cells lysate of 1044 
GT1-7 cells treated with LIF for times indicated above each lane. GnRH-reporter is 1045 
repressed by co-transfection with B, constitutively active (CA) RAS; C, CA MKK3 and 1046 
CA MKK6, upstream activators of p38; and D, CA p38α. Statistical significance, p < 1047 
0.05, indicated by *, was determined with ANOVA followed by Tukey’s post hoc test. . 1048 
 1049 
7. cFOS mediates LIF repression of the GnRH gene. A, LIF treatment of GT1-7 cells 1050 
induces cFOS, but not OCT-1, demonstrated by western blots of nuclear extracts. B, 1051 
Overexpression of cFOS, by co-transfection of cFOS expression vector, is sufficient to 1052 
repress GnRH E/P reporter. * indicates significant difference (p<0.05) determined with 1053 
t-test. C, Mutation of the cFOS binding site at -1793 abolishes LIF repression of GnRH 1054 
E/P reporter, demonstrated by transient transfections of reporters containing the 1055 
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mutations of the putative cFOS binding sites in GT1-7 cells. D, the same mutation was 1056 
created in the GnRH E/RSVp reporter and also abrogates the repression by LIF. 1057 
Statistical significance, p < 0.05 indicated by *, was determined with ANOVA followed by 1058 
Tukey’s post hoc test. 1059 
 1060 
8. More GnRH neurons express cFOS following high fat diet (HFD). A, Coronal 1061 
sections of the preoptic area in the hypothalamus of GnRH-GFP mice following HFD 1062 
stained for GFP (green) and cFOS (red). Scale bar represents 100 µm, white arrows 1063 
indicate GnRH neurons labeled with GFP and cFOS. Numbered squares correspond to 1064 
enlarged areas below; 1, GnRH neurons green, cFOS red; Arrows indicate GnRH 1065 
neurons that express cFOS, an arrowhead points to the GnRH neuron without cFOS; 2-1066 
3, DAPI channel is included to facilitate cell count; nuclei blue, cFOS magenta. Arrows 1067 
indicate cells labeled with cFOS and DAPI. B, quantification of neurons expressing 1068 
cFOS in control (CTR, white bars) and HFD male mice (black bars): 1, increase in the 1069 
percent of GnRH neurons with cFOS is observed in HFD compared to control. 2, 1070 
quantification of the neurons that express cFOS, proximal to the OVLT delineated with  1071 
#2 square; 3, quantification of the neurons that express cFOS, dorsally from the OVLT 1072 
delineated with #3 square following control and HFD. Three hundred GnRH neurons 1073 
were counted in each mouse. Statistical significance, p < 0.05 indicated by *, was 1074 
determined with t-test. 1075 
 1076 
 1077 
 1078 
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Table 1. 1079 
Antibody Species Dilution Provider, cat #  
GFP chicken  1:5000 Abcam, ab1397 
GP130 rat 1:300 R&D Systems, MAB4681; clone#125623 
STAT3 mouse 1:1000 Cell Signaling, 9139 
p-STAT3 rabbit 1:1000 Cell Signaling, 9145 
p38 rabbit 1:1000 Cell Signaling, 9212 
p-p38 rabbit 1:1000 Cell Signaling, 9211 
ERK 1/2 rabbit 1:1000 Cell Signaling, 9102 
p-ERK 1/2 rabbit 1:1000 Cell Signaling, 9101 
JNK rabbit 1:1000 Cell Signaling, 9252 
p-JNK mouse 1:1000 Cell Signaling, 9255 
OCT-1 rabbit 1:500 Abcam, ab66132 
cFOS rabbit 1:300, 1:1000 Santa Cruz Biotechnology, sc-52 
b-tubulin rabbit  1:1000 Santa Cruz Biotechnology, sc-9104 
 1080 
 1081 
Table 2. 1082 
 1083 
 1084 
Primers Forward Reverse 
Gnrh (GnRH) CTACTGCTGACTGTGTGTTTG CATCTTCTTCTGCCTGGCTTC 
Il6 (IL-6) TTCTCTGGGAAATCGTGGAAAT TCCAGTTTGGTAGCATCCATCA 
Tnfa (TNF-α) ATGTCTCAGCCTCTTCTCATTCC GCTTGTCACTCGAATTTTGAGAA 
Il1β (IL1β) GCAACTGTTCCTGAACTCAACTG CACAGCCACAATGAGTGATACTG 
Lif (LIF) ATGTGCGCCTAACATGACAG TATGCGACCATCCGATACAG 
B2m (beta-2-
microglobulin 
TGACCGGCCTGTATGCTATCCA 
CAGTGTGAGCCAGGATATAGAAAG
AC 
LIFR TCAGTTTCAGCCAGGAGTAA GCAATAATCAATCCCACAGA 
IL6R AAGCAGCAGGCAATGTTACC CATAAATAGTCCCCAGTGTCG 
GP130 GCGTACACAGATGAAGGTGGGAAAGA GCTGACTGCAGTTCTGCTTGA 
 1085 
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